Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer - from Molecular Signalling to Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|11|5|455-463

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.5, 2011-06, pp. : 455-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas

By Janus Joanna M.   O’Shaughnessy Ryan F. L.   Harwood Catherine A.   Maffucci Tania  

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 86-86

MDPI

Access to resources Recommend Favorite

Involvement of the phosphoinositide 3kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1

By                  

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 43-48

Spandidos Publications

Access to resources Recommend Favorite

Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways

By      

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3446-3452

Spandidos Publications

Access to resources Recommend Favorite

Ephrin typeA receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3kinase/Akt signalling pathway

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 924-930

Spandidos Publications

Access to resources Recommend Favorite

Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN

By            

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1305-1308

Spandidos Publications

Access to resources Recommend Favorite